While CAR-T therapies have revolutionized cancer treatment, access remains largely confined to major academic medical centers, limiting treatment availability for most eligible patients. Expanding delivery to community hospitals and regional oncology networks is critical to ensuring equitable access to these life-saving therapies. However, challenges such as FACT accreditation, provider readiness, and logistical hurdles have slowed progress. This session will explore scalable models for CAR-T therapy delivery beyond academic centers, focusing on hospital network expansion, regulatory enablement, and industry-provider collaboration. Experts from leading biopharma companies, provider networks, and accreditation bodies will share their experiences and strategies for accelerating access.